Wilk Technologies

Cultured Milk Production

Agriculture & Food Technologies
Public on TASE on Feb, 2021<br>
Follow

Company Overview

Snapshot

Founded in June 2018 by Nurit Argov-Argaman and Yaron Kaiser, Wilk Technologies operates with 11–50 employees. The company has raised a total of $9.19M across three funding rounds and holds a patent for its methods and systems. Wilk Technologies became public on TASE in February 2021 through a reverse merger with Fantasy Network.

Business overview

Wilk Technologies is dedicated to transforming the dairy industry by focusing on the sustainable production of high-value dairy products with a low carbon footprint. The company leverages over a decade of research to develop cultured milk from animals, cultured human breast milk, and high-grade human milk oligosaccharides (HMOs). Operating within the Agriculture & Food Technologies sector, Wilk Technologies serves the food tech and novel food ingredients markets.

Strategic signal

In May 2024, Wilk Technologies announced a collaboration with Pluri to develop human breast milk-derived food production on a commercial scale, targeting a novel medical food solution for the elderly. This partnership signals Wilk's strategic expansion into the medical food sector, validating its cell-based milk technology beyond traditional dairy alternatives and highlighting its potential to address specific nutritional needs in vulnerable populations.

Log in to access full profile

Company Intelligence Q&A

What was a significant recent operational change at Wilk Technologies?
In June 2024, Wilk Technologies announced that its CEO would conclude her tenure after less than nine months, as part of a streamlining plan for the company.
What strategic partnership did Wilk Technologies announce in 2024?
In May 2024, Wilk Technologies collaborated with Pluri to develop human breast milk-derived food production on a commercial scale, focusing on a novel medical food solution for the elderly.
When did Wilk Technologies receive a US patent for its technology?
Wilk Technologies received a U.S. patent for its cell-based milk production methods and systems in February 2022.
What was a key product development milestone for Wilk Technologies in 2022?
In November 2022, Wilk Technologies presented the world's first cell-based yogurt produced with cultured milk fat, following a project launch in July 2022 to develop this product.
Which investors participated in Wilk Technologies' strategic investment round in April 2023?
In April 2023, Wilk Technologies closed a strategic investment round led by.
Log in to access full profile